Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Glaukos Corporation    GKOS

GLAUKOS CORPORATION

(GKOS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/10/2020 01/13/2020 01/14/2020 01/15/2020 01/16/2020 Date
58.25(c) 58.94(c) 59.53(c) 57.99(c) 58.78(c) Last
403 427 308 850 266 976 275 814 276 376 Volume
+1.80% +1.18% +1.00% -2.59% +1.36% Change
More quotes
Financials (USD)
Sales 2019 244 M
EBIT 2019 -31,1 M
Net income 2019 -34,5 M
Finance 2019 96,5 M
Yield 2019 -
Sales 2020 315 M
EBIT 2020 -25,8 M
Net income 2020 -26,8 M
Finance 2020 96,7 M
Yield 2020 -
P/E ratio 2019 -70,9x
P/E ratio 2020 -107x
EV / Sales2019 10,0x
EV / Sales2020 7,77x
Capitalization 2 547 M
More Financials
Company
Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted... 
More about the company
Surperformance© ratings of Glaukos Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAUKOS CORPORATION
01/15GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/03GLAUKOS : Announces Participation in J.P. Morgan Healthcare Conference
BU
2019GLAUKOS CORP : Completion of Acquisition or Disposition of Assets, Regulation FD..
AQ
2019GLAUKOS : Completes Acquisition of Avedro, Inc.
BU
2019GLAUKOS : Announces Participation in Piper Jaffray Healthcare Conference
BU
2019GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2019GLAUKOS : 3Q Earnings Snapshot
AQ
2019GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2019GLAUKOS CORP : Results of Operations and Financial Condition, Financial Statemen..
AQ
2019GLAUKOS CORPORATION : Announces Third Quarter 2019 Financial Results
BU
2019GLAUKOS : Announces Participation in Stephens Investor Conference
BU
2019GLAUKOS CORPORATION : to Release Third Quarter 2019 Financial Results after Mark..
BU
2019GLAUKOS : Achieves Pipeline Milestone with Completion of Patient Enrollment in U..
BU
2019GLAUKOS : Products to be Subject of Multiple Presentations at American Academy o..
BU
2019GLAUKOS : rsquo; iStent inject® Delivers Greater IOP Reduction vs. iStent® Accor..
BU
More news
News in other languages on GLAUKOS CORPORATION
2017Les valeurs à suivre à Wall Street
More news
Sector news : Medical Devices & Implants
02:48aHealth Executives Brace for Change In Regulation and Competition -- WSJ
DJ
01:24aToshiba succeeds in bid for chip equipment unit, beating Hoya
RE
01/16Health Executives Gear Up for Change at J.P. Morgan Conference
DJ
01/15Toshiba closer to winning takeover bid for NuFlare with major shareholder bac..
RE
01/14SmileDirectClub jumps on plans to start selling aligners to dentists
RE
More sector news : Medical Devices & Implants
Chart GLAUKOS CORPORATION
Duration : Period :
Glaukos Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAUKOS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 65,50  $
Last Close Price 58,78  $
Spread / Highest target 36,1%
Spread / Average Target 11,4%
Spread / Lowest Target -3,03%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO, CAO & Senior VP-Corporate Development
L. Jay Katz Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORPORATION7.91%2 579
STRYKER CORPORATION-0.23%77 860
SMITH & NEPHEW PLC2.26%21 386
WRIGHT MEDICAL GROUP N.V.-1.12%3 907
INSPIRE MEDICAL SYSTEMS, INC.11.01%1 874
JAPAN LIFELINE CO., LTD.-1.08%1 064